Ralf Loebbert
AbbVie (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Alzheimer's disease research and treatments, Biosimilars and Bioanalytical Methods, Rheumatoid Arthritis Research and Therapies, Protein purification and stability
Most-Cited Works
- → Pharmacokinetics and Tolerability of a Dual Variable Domain Immunoglobulin ABT‐981 Against IL‐1α and IL‐1β in Healthy Subjects and Patients With Osteoarthritis of the Knee(2016)29 cited
- → Non-invasive characterization of β-amyloid1-40 vasoactivity by functional magnetic resonance imaging in mice(2008)23 cited
- → Laser capture microdissection and microarray analysis of dividing neural progenitor cells from the adult rat hippocampus(2007)17 cited
- → EBF Recommendation for Stability Testing of Anti-Drug Antibodies; Lessons Learned from Anti-Vaccine Antibody Stability Studies(2014)14 cited
- → Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection(2021)9 cited
- → SEC Based Method for Size Determination of Immune Complexes of Therapeutic Antibodies in Animal Matrix(2016)8 cited
- → Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor‐α and Interleukin 17A, ABBV‐257, in Healthy Volunteers and Patients With Rheumatoid Arthritis(2018)2 cited
- → THU0491 Dual Variable Domain-Immunoglobulin (DVD-IG™) ABT-981 Simultaneously and Dose-Dependently Inhibits Interleukin-1 Alpha and -1 Beta in Subjects with Knee Osteoarthritis(2015)1 cited
- → P2‐356: Guiding anti‐RAGE monoclonal antibody development for the treatment of Alzheimer's disease via imaging(2010)1 cited
- → P4–086: RAGE/Aβ1–42 binding characteristics and impact on LTP function(2006)